BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zejda JE, Brożek GM, Kowalska M, Barański K, Kaleta-Pilarska A, Nowakowski A, Xia Y, Buszman P. Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Random Sample of Inhabitants of the Katowice Region, Poland. Int J Environ Res Public Health 2021;18:3188. [PMID: 33808716 DOI: 10.3390/ijerph18063188] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Sugiyama A, Okada F, Abe K, Imada H, Ouoba S, E B, Hussain MRA, Ohisa M, Ko K, Nagashima S, Akita T, Yamazaki S, Yokozaki M, Kishita E, Tanaka J. A longitudinal study of anti-SARS-CoV-2 antibody seroprevalence in a random sample of the general population in Hiroshima in 2020. Environ Health Prev Med 2022;27:30. [PMID: 35793938 DOI: 10.1265/ehpm.22-00016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Hajissa K, Islam MA, Hassan SA, Zaidah AR, Ismail N, Mohamed Z. Seroprevalence of SARS-CoV-2 Antibodies in Africa: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health 2022;19:7257. [PMID: 35742506 DOI: 10.3390/ijerph19127257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Levin AT, Owusu-Boaitey N, Pugh S, Fosdick BK, Zwi AB, Malani A, Soman S, Besançon L, Kashnitsky I, Ganesh S, McLaughlin A, Song G, Uhm R, Herrera-Esposito D, de Los Campos G, Peçanha Antonio ACP, Tadese EB, Meyerowitz-Katz G. Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications. BMJ Glob Health 2022;7:e008477. [PMID: 35618305 DOI: 10.1136/bmjgh-2022-008477] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 19.0] [Reference Citation Analysis]
4 Smagul M, Esmagambetova A, Nusupbaeva G, Kirpicheva U, Kasabekova L, Nukenova G, Saliev T, Fakhradiyev I, Tanabayeva S, Zhussupov B. Sero‐prevalence of SARS‐CoV‐2 in certain cities of Kazakhstan. Health Science Reports 2022;5. [DOI: 10.1002/hsr2.562] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Korona-Głowniak I, Mielnik M, Podgajna M, Grywalska E, Hus M, Matuska K, Wojtysiak-Duma B, Duma D, Glowniak A, Malm A. SARS-CoV-2 Seroprevalence in Healthcare Workers before the Vaccination in Poland: Evolution from the First to the Second Pandemic Outbreak. Int J Environ Res Public Health 2022;19:2319. [PMID: 35206504 DOI: 10.3390/ijerph19042319] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Martínez PT, García PD, Salas MR, Sánchez RR, Avendaño-Ortíz J, Guerrero-Monjo S, García F, Llamas MÁ, López-Collazo E, Saz-Leal P, Del Fresno C. SARS-CoV-2 IgG seropositivity in a cohort of 449 non-hospitalized individuals during Spanish COVID-19 lockdown. Sci Rep 2021;11:21612. [PMID: 34732800 DOI: 10.1038/s41598-021-00990-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Richard A, Wisniak A, Perez-Saez J, Garrison-Desany H, Petrovic D, Piumatti G, Baysson H, Picazio A, Pennacchio F, De Ridder D, Chappuis F, Vuilleumier N, Low N, Hurst S, Eckerle I, Flahault A, Kaiser L, Azman AS, Guessous I, Stringhini S. Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study. Scand J Public Health 2021;:14034948211048050. [PMID: 34664529 DOI: 10.1177/14034948211048050] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
8 Hannum ME, Koch RJ, Ramirez VA, Marks SS, Toskala AK, Herriman RD, Lin C, Joseph PV, Reed DR. Taste loss as a distinct symptom of COVID-19: A systematic review and meta-analysis. medRxiv 2021:2021. [PMID: 34671775 DOI: 10.1101/2021.10.09.21264771] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Levin A, Owusu-boaitey N, Pugh S, Fosdick BK, Zwi AB, Malani A, Soman S, Besançon L, Kashnitsky I, Ganesh S, Mclaughlin A, Song G, Uhm R, Herrera-esposito D, de los Campos G, Pecanha Antiono AC, Tadese EB, Meyerowitz-katz G. Assessing the Burden of COVID-19 in Developing Countries: Systematic Review, Meta-Analysis, and Public Policy Implications.. [DOI: 10.1101/2021.09.29.21264325] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
10 Gajda M, Kowalska M, Zejda JE. Impact of Two Different Recruitment Procedures (Random vs. Volunteer Selection) on the Results of Seroepidemiological Study (SARS-CoV-2). Int J Environ Res Public Health 2021;18:9928. [PMID: 34574850 DOI: 10.3390/ijerph18189928] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Vilibic-Cavlek T, Stevanovic V, Ilic M, Barbic L, Capak K, Tabain I, Krleza JL, Ferenc T, Hruskar Z, Topic RZ, Kaliterna V, Antolovic-Pozgain A, Kucinar J, Koscak I, Mayer D, Sviben M, Antolasic L, Milasincic L, Bucic L, Ferencak I, Kaic B. SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia. Pathogens 2021;10:774. [PMID: 34203060 DOI: 10.3390/pathogens10060774] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
12 Kowalska M, Niewiadomska E, Barański K, Kaleta-Pilarska A, Brożek G, Zejda JE. Association between Influenza Vaccination and Positive SARS-CoV-2 IgG and IgM Tests in the General Population of Katowice Region, Poland. Vaccines (Basel) 2021;9:415. [PMID: 33919206 DOI: 10.3390/vaccines9050415] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
13 Barański K, Brożek G, Kowalska M, Kaleta-Pilarska A, Zejda JE. Impact of COVID-19 Pandemic on Total Mortality in Poland. Int J Environ Res Public Health 2021;18:4388. [PMID: 33924261 DOI: 10.3390/ijerph18084388] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]